COMBINED EFFECT OF OBETICHOLIC ACID AND BEZAFIBRATE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS AND INADEQUATE RESPONSE TO OR INTOLERANCE OF URSODEOXYCHOLIC ACID: RESULTS FROM TWO PHASE 2 CLINICAL TRIALS

被引：0

作者：

Levy, Cynthia ^{[1
]}

Hejda, Vaclav ^{[2
]}

Louvet, Alexandre ^{[3
]}

Younes, Ziad ^{[4
]}

Mendizabal, Manuel ^{[5
]}

Bonder, Alan ^{[6
]}

Zou, Heng ^{[7
]}

Civitarese, Antonio ^{[7
]}

Villamil, Alejandra ^{[8
]}

Nevens, Frederik ^{[9
]}

机构：

[1] Univ Miami, Sch Med, Coral Gables, FL 33124 USA

[2] Univ Hosp Plzen, Plzen, Czech Republic

[3] Univ Hosp Lille, Lille, France

[4] Gastro One, Germantown, TN USA

[5] Hosp Univ Austral, Pilar, Argentina

[6] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA

[7] Intercept Pharmaceut Inc, Morristown, NJ USA

[8] Hosp Italiano Buenos Aires, Hepat Autoimmun Unit, Buenos Aires, DF, Argentina

[9] Univ Hosp KU Leuven, Leuven, Belgium

来源：

HEPATOLOGY | 2024年 / 79卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

5019-C

引用

页码：E52 / E52

页数：1

共 50 条

[21] Obeticholic Acid Improves Aminotransferases Early during Treatment in Patients with Primary Biliary Cholangitis Not Responding to Ursodeoxycholic Acid: A Study in Clinical Practice
Labanca, Sara
Cacciato, Valentina
Borro, Paolo
Marenco, Simona
Pieri, Giulia
Picciotto, Antonino
Torres, Maria Corina Plaz
Giannini, Edoardo G.
IMMUNO, 2021, 1 (04): : 457 - 467
[22] Changes in serum bile acid levels associated with bezafibrate add-on therapy in patients with primary biliary cholangitis and inadequate biochemical response to ursodeoxycholic acid: results from the BEZURSO trial (NCT01654731)
Corpechot, Christophe
Chazouilleres, Olivier
Humbert, Lydie
Rousseau, Alexandra
Le Gruyer, Antonia
Habersetzer, Francois
Mathurin, Philippe
Goria, Odile
Potier, Pascal
Anne, Minello
Silvain, Christine
Abergel, Armando
Debette-Gratien, Maryline
Larrey, Dominique G.
Roux, Olivier
Bronowicki, Jean-Pierre
Boursier, Jerome
de Ledinghen, Victor
Heurgue-Berlot, Alexandra
Nguyen-Khac, Eric
Zoulim, Fabien
Ollivier-Hourmand, Isabelle
Zarski, Jean-Pierre H.
Nkontchou, Gisele
Gaouar, Farid
Simon, Tabassome
Poupon, Raoul
Rainteau, Dominique
HEPATOLOGY, 2017, 66 : 168A - 168A
[23] Bacterial and metabolic phenotypes associated with inadequate response to ursodeoxycholic acid treatment in primary biliary cholangitis
Martinez-Gili, Laura
Pechlivanis, Alexandros
McDonald, Julie A. K.
Begum, Sofina
Badrock, Jonathan
Dyson, Jessica K.
Jones, Rebecca
Hirschfield, Gideon
Ryder, Stephen D.
Sandford, Richard
Rushbrook, Simon
Thorburn, Douglas
Taylor-Robinson, Simon D.
Crossey, Mary M. E.
Marchesi, Julian R.
Mells, George
Holmes, Elaine
Jones, David
GUT MICROBES, 2023, 15 (01)
[24] OBETICHOLIC ACID AND BEZAFIBRATE IN PRIMARY BILIARY CHOLANGITIS: A COMPARATIVE EVALUATION OF EFFICACY THROUGH REAL WORLD CLINICAL PRACTICE
Culver, Emma
Hayden, Jennifer
Thorburn, Douglas
Marshall, Aileen
Aspinall, Richard
Dimmer, Alison
Swabe, Jacqueline
Hydes, Theresa
Khakoo, Salim I.
Williams, Elizabeth
Maurice, James
Burke, Niall
Kallis, Yiannis
Smith, Bellinda
Patanwala, Imran
Orrell, Michael
Barr, Julie
Ryder, Stephen D.
Ellis, Tom
Dilks, Breanne
Bird, Samantha
Day, Darren
Williamson, Kate D.
Moreea, Sulleman
Tinker, Samantha
Mccune, Anne
Corless, Lynsey
Jones, Rebecca
Chimakurthi, Chenchu
Miah, Zohur
Mells, George
Jones, David
Hirschfield, Gideon
Trivedi, Palak
HEPATOLOGY, 2019, 70 : 770A - 770A
[25] ADDITIVE BENEFICIAL EFFECTS OF FIBRATES COMBINED WITH OBETICHOLIC ACID IN THE TREATMENT OF PATIENTS WITH PRIMARY BILIARY CHOLANGITIS AND INADEQUATE RESPONSE TO SECOND-LINE THERAPY
Soret, Pierre-Antoine
Lam, Laurent
Carrat, Fabrice
Smets, Lena
Leroy, Vincent
Berg, Thomas
Carbone, Marco
Invernizzi, Pietro
Trivedi, Palak
Weiler-Normann, Christina
Alric, Laurent
Rosa, Isabelle
Cervoni, Jean-Paul
Dumortier, Jerome
Potier, Pascal
Roux, Olivier
Silvain, Christine
Levy, Cynthia
Pares, Albert
Schramm, Christoph
Nevens, Frederick
Chazouilleres, Olivier
Corpechot, Christophe
HEPATOLOGY, 2019, 70 (06) : 1491A - 1492A
[26] PROMISING EFFECTS OF BEZAFIBRATE IN PATIENTS WITH PRIMARY BILIARY CIRRHOSIS AND INCOMPLETE RESPONSE TO URSODEOXYCHOLIC ACID
Lens, S.
Leoz, M.
Nazal, L.
Bruguera, M.
Pares, A.
JOURNAL OF HEPATOLOGY, 2011, 54 : S512 - S512
[27] Ustekinumab for Patients With Primary Biliary Cholangitis Who Have an Inadequate Response to Ursodeoxycholic Acid: A Proof-of-Concept Study
Hirschfield, Gideon M.
Gershwin, M. Eric
Strauss, Richard
Mayo, Marlyn J.
Levy, Cynthia
Zou, Bin
Johanns, Jewel
Nnane, Ivo P.
Dasgupta, Bidisha
Li, Katherine
Selmi, Carlo
Marschall, Hanns-Ulrich
Jones, David
Lindor, Keith
HEPATOLOGY, 2016, 64 (01) : 189 - 199
[28] Impact of the metabolic profile on the response to ursodeoxycholic acid in patients with primary biliary cholangitis: results of the ColHai registry
Diaz Gonzalez, Alvaro
Gonzalez Pascual, Andrea
Gomez-Camarero, Judith
Gomez Dominguez, Elena
Carlota Londono, Maria
Vergara Gomez, Mercedes
Ampuero, Javier
Martinez, Javier
Horta, Diana
Gallego, Adolgo
Salmeron, Javier
Garcia-Retortillo, Montserrat
Morillas, Rosa M.
Andrade, Raul J.
Turnes, Juan
Diago, Moises
El Hajra Martinez, Ismael
Roget Alemany, Merce
Hernandez Guerra, Manuel
Quintans, Nerea
Sala, Margarita
Dominguez, Nuria
Arencibia Almeida, Ana
Crespo, Javier
Barreira, Ana
Salcedo, Magdalena
Riveiro Barciela, Mar
JOURNAL OF HEPATOLOGY, 2023, 78 : S376 - S377
[29] Effect of deferred or no treatment with ursodeoxycholic acid in patients with early primary biliary cholangitis
Tanaka, Atsushi
Hirohara, Junko
Nakano, Toshiaki
Yagi, Minami
Namisaki, Tadashi
Yoshiji, Hitoshi
Nakanuma, Yasuni
Takikawa, Hajime
HEPATOLOGY RESEARCH, 2018, 48 (09) : 727 - 734
[30] Bezafibrate normalizes alkaline phosphatase in primary biliary cirrhosis patients with incomplete response to ursodeoxycholic acid
Lens, Sabela
Leoz, Maria
Nazal, Leyla
Bruguera, Miguel
Pares, Albert
LIVER INTERNATIONAL, 2014, 34 (02) : 197 - 203

← 1 2 3 4 5 →